MMP2 and breast cancer: Consistently, we show here that ISO treatment upregulated miR-137 through promoting the phosphorylation of c-Jun at Ser73, consequently resulting in the inhibition of GSK3β-HSP70 protein translation, MMP-2 protein elevation, and BC cell invasion.